{"id":"https://openalex.org/W4308387643","doi":"https://doi.org/10.1016/j.molmet.2022.101633","title":"BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy","display_name":"BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy","publication_year":2022,"publication_date":"2022-11-07","ids":{"openalex":"https://openalex.org/W4308387643","doi":"https://doi.org/10.1016/j.molmet.2022.101633","pmid":"https://pubmed.ncbi.nlm.nih.gov/36356832","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9679702"},"language":"en","primary_location":{"id":"doi:10.1016/j.molmet.2022.101633","doi":"https://doi.org/10.1016/j.molmet.2022.101633","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2022.101633","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2212877822002022/pdf","source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2212877822002022/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110999901","display_name":"Tina Zimmermann","orcid":"https://orcid.org/0009-0005-0640-1977","observed_orcids":["https://orcid.org/0009-0005-0640-1977"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tina Zimmermann","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: tina.zimmermann@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: tina.zimmermann@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061499869","display_name":"Leo H. Thomas","orcid":"https://orcid.org/0000-0002-2156-7298","observed_orcids":["https://orcid.org/0000-0002-2156-7298"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Leo Thomas","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: leo.thomas@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: leo.thomas@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010246793","display_name":"Tamara Baader-Pagler","orcid":"https://orcid.org/0000-0002-1672-8739","observed_orcids":["https://orcid.org/0000-0002-1672-8739"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tamara Baader-Pagler","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: tamara.baader-pagler@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: tamara.baader-pagler@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048995307","display_name":"Peter Haebel","orcid":"https://orcid.org/0009-0000-5861-9613","observed_orcids":["https://orcid.org/0009-0000-5861-9613"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Haebel","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: peter.haebel@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: peter.haebel@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eric Simon","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: eric.simon@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: eric.simon@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wolfgang Reindl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Reindl","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: wolfgang.reindl@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: wolfgang.reindl@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048547230","display_name":"Besnik Bajrami","orcid":"https://orcid.org/0000-0002-3827-8150","observed_orcids":["https://orcid.org/0000-0002-3827-8150"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Besnik Bajrami","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: besnik.bajrami@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: besnik.bajrami@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039588975","display_name":"Wolfgang Rist","orcid":"https://orcid.org/0000-0002-0626-3544","observed_orcids":["https://orcid.org/0000-0002-0626-3544"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Rist","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: wolfgang.rist@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: wolfgang.rist@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031652160","display_name":"Ingo Uphues","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ingo Uphues","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: ingo.uphues@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: ingo.uphues@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057472647","display_name":"Daniel J. Drucker","orcid":"https://orcid.org/0000-0001-6688-8127","observed_orcids":["https://orcid.org/0000-0001-6688-8127"]},"institutions":[{"id":"https://openalex.org/I1291836623","display_name":"Mount Sinai Hospital","ror":"https://ror.org/05deks119","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1291836623","https://openalex.org/I4210130843"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Daniel J. Drucker","raw_affiliation_strings":["Lunenfeld-Tanenbaum Research Institute, University of Toronto, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada. Electronic address: drucker@lunenfeld.ca","Lunenfeld-Tanenbaum Research Institute, University of Toronto, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lunenfeld-Tanenbaum Research Institute, University of Toronto, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada. Electronic address: drucker@lunenfeld.ca","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I185261750","https://openalex.org/I210557978"]},{"raw_affiliation_string":"Lunenfeld-Tanenbaum Research Institute, University of Toronto, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada","institution_ids":["https://openalex.org/I1291836623","https://openalex.org/I185261750","https://openalex.org/I210557978"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Holger Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Holger Klein","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: holger.klein@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: holger.klein@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001642730","display_name":"Rakesh Santhanam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rakesh Santhanam","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: rakesh.santhanam@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: rakesh.santhanam@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017207819","display_name":"Dieter W. Hamprecht","orcid":"https://orcid.org/0000-0002-8858-3153","observed_orcids":["https://orcid.org/0000-0002-8858-3153"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]},{"id":"https://openalex.org/I4210095727","display_name":"Boehringer Ingelheim (Italy)","ror":"https://ror.org/00px03f62","country_code":"IT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210095727"]}],"countries":["DE","IT"],"is_corresponding":false,"raw_author_name":"Dieter Hamprecht","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany; Boehringer Ingelheim Research Italia, Via Lorenzini 8, 20139 Milano, Italy. Electronic address: Dieter.Hamprecht@pharmaxis.com.au","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","Boehringer Ingelheim Research Italia, Via Lorenzini 8, 20139 Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany; Boehringer Ingelheim Research Italia, Via Lorenzini 8, 20139 Milano, Italy. Electronic address: Dieter.Hamprecht@pharmaxis.com.au","institution_ids":["https://openalex.org/I4210095727"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Research Italia, Via Lorenzini 8, 20139 Milano, Italy","institution_ids":["https://openalex.org/I4210095727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073073730","display_name":"Heike Neubauer","orcid":"https://orcid.org/0000-0001-8470-968X","observed_orcids":["https://orcid.org/0000-0001-8470-968X"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heike Neubauer","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: heike.neubauer@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: heike.neubauer@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083460732","display_name":"Robert Augustin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Robert Augustin","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: Robert.augustin@boehringer-ingelheim.com","Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany. Electronic address: Robert.augustin@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I1330995197"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88400 Biberach an der Ri\u03b2, Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5083460732"],"corresponding_institution_ids":["https://openalex.org/I1330995197"],"apc_list":{"value":3360,"currency":"USD","value_usd":3360},"apc_paid":{"value":3360,"currency":"USD","value_usd":3360},"fwci":13.8229,"has_fulltext":true,"cited_by_count":156,"citation_normalized_percentile":{"value":0.9967312,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"66","issue":null,"first_page":"101633","last_page":"101633"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.12620000541210175,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxyntomodulin","display_name":"oxyntomodulin","score":0.9240000247955322},{"id":"https://openalex.org/keywords/glucagon-receptor","display_name":"glucagon receptor","score":0.7879999876022339},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.9929999709129333},{"id":"https://openalex.org/keywords/dual-agonist","display_name":"dual agonist","score":0.847000002861023},{"id":"https://openalex.org/keywords/anti-obesity-effect","display_name":"anti-obesity","score":0.6819999814033508},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7390000224113464},{"id":"https://openalex.org/keywords/energy-expenditure","display_name":"energy expenditure","score":0.9760000109672546},{"id":"https://openalex.org/keywords/food-consumption","display_name":"dietary intake","score":0.9800000190734863},{"id":"https://openalex.org/keywords/nicotinamide-n-methyltransferase","display_name":"nicotinamide N-methyltransferase","score":0.8740000128746033},{"id":"https://openalex.org/keywords/fgf21","display_name":"FGF21","score":0.9229999780654907},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.7390000224113464},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.7620000243186951},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C2778542361","wikidata":"https://www.wikidata.org/wiki/Q14904911","display_name":"Glucagon receptor","level":4,"score":0.8251388669013977},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6654574871063232},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6505407691001892},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.5739545226097107},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5712016224861145},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.52298903465271},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4817245304584503},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.41794970631599426},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.4136173129081726},{"id":"https://openalex.org/C2777369949","wikidata":"https://www.wikidata.org/wiki/Q567709","display_name":"Anorectic","level":3,"score":0.41160619258880615},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39751487970352173},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37011000514030457},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.3606961965560913},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3122272491455078},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2736924886703491},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2301172912120819},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.21910980343818665},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.20465481281280518},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.13500872254371643},{"id":"https://openalex.org/C3018685816","wikidata":"https://www.wikidata.org/wiki/Q213449","display_name":"Food intake","level":2,"score":0.09009671211242676},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D053772","descriptor_name":"Oxyntomodulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.molmet.2022.101633","doi":"https://doi.org/10.1016/j.molmet.2022.101633","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2022.101633","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2212877822002022/pdf","source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},{"id":"pmid:36356832","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36356832","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9679702","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9679702/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Metab","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:17b23caf79c94158be502e566134d4c5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/17b23caf79c94158be502e566134d4c5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Metabolism, Vol 66, Iss , Pp 101633- (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.molmet.2022.101633","doi":"https://doi.org/10.1016/j.molmet.2022.101633","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.molmet.2022.101633","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2212877822002022/pdf","source":{"id":"https://openalex.org/S2764545133","display_name":"Molecular Metabolism","issn_l":"2212-8778","issn":["2212-8778"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8634282901","display_name":null,"funder_award_id":"NNF19SA0035502","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"}],"funders":[{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308387643.pdf","grobid_xml":"https://content.openalex.org/works/W4308387643.grobid-xml"},"referenced_works_count":89,"referenced_works":["https://openalex.org/W3062643","https://openalex.org/W1773084519","https://openalex.org/W1856151485","https://openalex.org/W1942849356","https://openalex.org/W1991584810","https://openalex.org/W2002364623","https://openalex.org/W2045325331","https://openalex.org/W2049331373","https://openalex.org/W2049375442","https://openalex.org/W2057210916","https://openalex.org/W2059975776","https://openalex.org/W2061653993","https://openalex.org/W2081666098","https://openalex.org/W2089401171","https://openalex.org/W2089455486","https://openalex.org/W2110720647","https://openalex.org/W2115939390","https://openalex.org/W2118019244","https://openalex.org/W2122188063","https://openalex.org/W2126889125","https://openalex.org/W2132169136","https://openalex.org/W2132295069","https://openalex.org/W2135978651","https://openalex.org/W2137526110","https://openalex.org/W2137781433","https://openalex.org/W2146512944","https://openalex.org/W2148623180","https://openalex.org/W2154325494","https://openalex.org/W2154497567","https://openalex.org/W2155226662","https://openalex.org/W2156246748","https://openalex.org/W2159100311","https://openalex.org/W2170585132","https://openalex.org/W2176931287","https://openalex.org/W2244700942","https://openalex.org/W2414629446","https://openalex.org/W2464238397","https://openalex.org/W2512530949","https://openalex.org/W2554727807","https://openalex.org/W2591832038","https://openalex.org/W2754933198","https://openalex.org/W2765978794","https://openalex.org/W2773852483","https://openalex.org/W2782521891","https://openalex.org/W2785815156","https://openalex.org/W2789001384","https://openalex.org/W2791767508","https://openalex.org/W2792330843","https://openalex.org/W2795481136","https://openalex.org/W2806668299","https://openalex.org/W2807500148","https://openalex.org/W2891186944","https://openalex.org/W2895135221","https://openalex.org/W2899389750","https://openalex.org/W2899736836","https://openalex.org/W2900829579","https://openalex.org/W2904866297","https://openalex.org/W2912933215","https://openalex.org/W2924479779","https://openalex.org/W2955219150","https://openalex.org/W2959837219","https://openalex.org/W3009068954","https://openalex.org/W3010682058","https://openalex.org/W3016119493","https://openalex.org/W3027852565","https://openalex.org/W3043179056","https://openalex.org/W3084101089","https://openalex.org/W3088075449","https://openalex.org/W3115965039","https://openalex.org/W3128500266","https://openalex.org/W3136522906","https://openalex.org/W3155957136","https://openalex.org/W3159450286","https://openalex.org/W3160688142","https://openalex.org/W3184411983","https://openalex.org/W3185156700","https://openalex.org/W3196916730","https://openalex.org/W3197515876","https://openalex.org/W3197797081","https://openalex.org/W3209664507","https://openalex.org/W3211682263","https://openalex.org/W3217337816","https://openalex.org/W4210869062","https://openalex.org/W4214764520","https://openalex.org/W4214815915","https://openalex.org/W4296297570","https://openalex.org/W4386570539","https://openalex.org/W6774716140","https://openalex.org/W6838905883"],"related_works":["https://openalex.org/W2053470401","https://openalex.org/W4381376491","https://openalex.org/W4281787239","https://openalex.org/W4381734495","https://openalex.org/W2122188063","https://openalex.org/W4361190240","https://openalex.org/W4311822262","https://openalex.org/W3197370377","https://openalex.org/W2026149528","https://openalex.org/W7100177589"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Obesity":[1],"and":[2,17,33,38,45,91,102,104,164,181,188,194,214,221,225,249],"its":[3],"associated":[4],"comorbidities":[5],"represent":[6],"a":[7,12,24,112,117,122,235],"global":[8],"health":[9],"challenge":[10],"with":[11,144,240],"need":[13],"for":[14,99,185,202],"well-tolerated,":[15],"effective,":[16],"mechanistically":[18],"diverse":[19],"pharmaceutical":[20],"interventions.":[21],"Oxyntomodulin":[22],"is":[23,111,157,234],"gut":[25],"peptide":[26,115],"that":[27],"activates":[28],"the":[29,54,58,100,149,158,186,203,212],"glucagon":[30,60],"receptor":[31,36,61,63],"(GCGR)":[32],"glucagon-like":[34],"peptide-1":[35],"(GLP-1R)":[37,64],"reduces":[39],"bodyweight":[40,139],"by":[41,245],"increasing":[42,246],"energy":[43,47,162,247],"expenditure":[44,163,248],"reducing":[46],"intake":[48],"in":[49,76,130,141,172],"humans.":[50,131],"Here":[51],"we":[52],"describe":[53],"pharmacological":[55,85],"profile":[56],"of":[57,134,148,160,169,208],"novel":[59],"(GCGR)/GLP-1":[62],"dual":[65,206,238],"agonist":[66,151,239],"BI":[67,70,109,135,153,209,232],"456906.":[68],"METHODS:":[69],"456906":[71,110,136,210,233],"was":[72,174,216],"characterized":[73],"using":[74,89,218],"cell-based":[75],"vitro":[77],"assays":[78],"to":[79,95,126],"determine":[80],"functional":[81],"agonism.":[82],"In":[83],"vivo":[84,173,228],"studies":[86],"were":[87],"performed":[88],"acute":[90],"subchronic":[92],"dosing":[93,129],"regimens":[94],"demonstrate":[96],"target":[97],"engagement":[98],"GCGR":[101,215],"GLP-1R,":[103,187],"weight":[105],"lowering":[106],"efficacy.":[107],"RESULTS:":[108],"potent,":[113],"acylated":[114],"containing":[116],"C18":[118],"fatty":[119],"acid":[120],"as":[121],"half-life":[123],"extending":[124],"principle":[125],"support":[127],"once-weekly":[128],"Pharmacological":[132],"doses":[133,147],"provided":[137],"greater":[138],"reductions":[140],"mice":[142],"compared":[143],"maximally":[145],"effective":[146],"GLP-1R":[150,213,219],"semaglutide.":[152],"456906's":[154],"superior":[155],"efficacy":[156,243],"consequence":[159],"increased":[161],"reduced":[165],"food":[166,179,251],"intake.":[167,252],"Engagement":[168],"both":[170],"receptors":[171],"demonstrated":[175],"via":[176],"glucose":[177],"tolerance,":[178],"intake,":[180],"gastric":[182],"emptying":[183],"tests":[184],"liver":[189],"nicotinamide":[190],"N-methyltransferase":[191],"mRNA":[192],"expression":[193],"circulating":[195],"biomarkers":[196],"(amino":[197],"acids,":[198],"fibroblast":[199],"growth":[200],"factor-21)":[201],"GCGR.":[204],"The":[205],"activity":[207],"at":[211],"supported":[217],"knockout":[220],"transgenic":[222],"reporter":[223],"mice,":[224],"an":[226],"ex":[227],"bioactivity":[229],"assay.":[230],"CONCLUSIONS:":[231],"potent":[236],"GCGR/GLP-1R":[237],"robust":[241],"anti-obesity":[242],"achieved":[244],"decreasing":[250]},"counts_by_year":[{"year":2026,"cited_by_count":45},{"year":2025,"cited_by_count":39},{"year":2024,"cited_by_count":50},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-11-11T00:00:00"}